首页> 美国卫生研究院文献>PLoS Clinical Trials >Inhibition of Multidrug Resistance by SV40 Pseudovirion Delivery of an Antigene Peptide Nucleic Acid (PNA) in Cultured Cells
【2h】

Inhibition of Multidrug Resistance by SV40 Pseudovirion Delivery of an Antigene Peptide Nucleic Acid (PNA) in Cultured Cells

机译:SV40伪病毒粒子在培养细胞中传递抗原肽核酸(PNA)抑制多药耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peptide nucleic acid (PNA) is known to bind with extraordinarily high affinity and sequence-specificity to complementary nucleic acid sequences and can be used to suppress gene expression. However, effective delivery into cells is a major obstacle to the development of PNA for gene therapy applications. Here, we present a novel method for the in vitro delivery of antigene PNA to cells. By using a nucleocapsid protein derived from Simian virus 40, we have been able to package PNA into pseudovirions, facilitating the delivery of the packaged PNA into cells. We demonstrate that this system can be used effectively to suppress gene expression associated with multidrug resistance in cancer cells, as shown by RT-PCR, flow cytometry, Western blotting, and cell viability under chemotherapy. The combination of PNA with the SV40-based delivery system is a method for suppressing a gene of interest that could be broadly applied to numerous targets.
机译:已知肽核酸(PNA)以极高的亲和力和序列特异性与互补核酸序列结合,可用于抑制基因表达。然而,有效递送到细胞中是基因治疗应用PNA发展的主要障碍。在这里,我们提出了一种新方法,用于将抗原PNA体外递送到细胞中。通过使用源自猿猴病毒40的核衣壳蛋白,我们已经能够将PNA包装到假病毒颗粒中,从而有助于将包装的PNA运送到细胞中。我们证明了该系统可以有效地抑制与癌细胞中多药耐药性相关的基因表达,如RT-PCR,流式细胞仪,Western印迹和化疗下的细胞生存力所示。 PNA与基于SV40的递送系统的组合是一种抑制目标基因的方法,该方法可广泛应用于许多靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号